Targeted cancer therapeutics: The heartbreak of success

Nature Medicine

Volumn 12, Issue 8, 2006, Pages 881-882

  Mann, Douglas L ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ADENOSINE TRIPHOSPHATE; DOXORUBICIN; HYDROGEN PEROXIDE; IMATINIB; INITIATION FACTOR 2ALPHA; PROTEIN TYROSINE KINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SUNITINIB; TRASTUZUMAB;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL TRIAL; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; DYSPNEA; EDEMA; ENDOPLASMIC RETICULUM; GENOTOXICITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; KIDNEY CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SHORT SURVEY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; ENZYME INHIBITORS; HEART FAILURE, CONGESTIVE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MODELS, BIOLOGICAL; NEOPLASMS; PIPERAZINES; PYRIMIDINES; SRC-FAMILY KINASES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33746835690     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0806-881     Document Type: Short Survey

References (7)

1. Slamon, D.J. et al. N. Engl. J. Med. 344, 783-792 (2001).
2. Crone, S.A. et al. Nat. Med. 8, 459-465 (2002).
3. Kerkelä, R. et al. Nat. Med. 12, 908-916 (2006).
4. Druker, B.J. et al. N. Engl. J. Med. 344, 1031-1037 (2001).
5. Terai, K. et al. Mol. Cell Biol. 25, 9554-9575 (2005).
6. Boyce, M. & Yuan, J. Cell Death. Differ. 13, 363-373 (2006).
7. Kumar, S. et al. J. Biol. Chem. 276, 17281-17285 (2001).